Tag archive for ‘BIOLINERX.’
Jewish Business News On Friday, March 6th, 2015

Israeli BioLineRx Announces Underwritten Public Offering of American Depositary Shares

Israeli Drug development company BiolineRX Ltd. (Nasdaq: BLRX); TASE:BLRX) has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing ten (10) of its More...

Alan Gallindoss On Wednesday, December 11th, 2013

Edison Investment Research Shows Confidence Sets Up Shop In Israel

UK based Edison Investment Research, which describes itself as an “investment intelligence company”, has just announced it has extended the company’s presence to Israel with the appointment More...

Kitov completes its merger into Mainrom

– Dr. Paul Waymack , who lives in Washington DC in the U.S., will be chairman of the board of directors, The company has two late stage (Phase 3) drugs ready for clinical trials. – Dr. Paul More...

BioLineRx licenses $30 million deal value for Hepatitis C drug to Chinese CTTQ co

– BioLineRx has signed an agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. (CTTQ) for the development and commercialization of BL-8030, an oral treatment for the Hepatitis C virus More...

Wordpress site Developed by Fixing WordPress Problems